Galderma Achieves Record Sales in Medical Aesthetics, Alma Expands in Japan, and AbbVie's Market Success

December 1, 2023
Galderma, a global leader in medical aesthetics, achieved a record-breaking net sales of over 3 billion USD in the first nine months of 2023, demonstrating an 8.9% increase from the previous year. This success is largely due to their extensive dermatology portfolio, including advancements in nemolizumab and RelabotulinumtoxinA, and the growth of Alastin Skincare.

Alma, part of Sisram Medical, has expanded its presence in the Asia Pacific region by establishing a new subsidiary in Japan. This strategic move is aimed at enhancing their market position and providing Japanese healthcare professionals with access to their innovative energy-based medical solutions.

AbbVie Inc. has also made significant strides in the market, with its stock performance indicating a strong foothold in the medical aesthetics sector.

These developments underscore the continuous innovation and growth within the medical aesthetics industry, led by key players such as Galderma, Alma, and AbbVie.

 

Editor's Pick

Information and Communication Technology

Google One’s 100 mn Subscribers Coincide with Gemini Advanced Plan
February 19, 2024

Information and Communication Technology

LumiraDx Sells Point of Care Technology Platform to Roche
February 19, 2024

PODCASTS

Sustainable Digital Transformation & Industry 4.0

Sustainable Digital Transformation & Industry 4.0

Sanjay Kaul, President-Asia Pacific & Japan, Cisco, and host Aashish Mehra, Chief Research Officer, MarketsandMarkets, in conversation on unraveling 'Sustainable Digital Transformation and Industry 4.0'

11 July 2023|S2E12|Listen Now

Future of Utilities with Thomas Birr from E.ON

Generative AI

Prasad Joshi, Senior Vice President-Emerging Technology Solutions, Infosys, and host, Vinod Chikkareddy, CCO, MarketsandMarkets, in exploring the recent advances in AI and the generative AI space.

7 Nov 2023|S2E13|Listen Now

Medical Aesthetics Industry

$15.4 BN
2023
$25.9 BN
2028

Download Whitepaper

The success is largely due to their extensive dermatology portfolio.

Strategic move is aimed at enhancing their market position and providing Japanese healthcare professionals with access to their innovative energy-based medical solutions.

STAY TUNED

GET EMAIL ALERT
Subscribe Email

Follow IndustryNews by MarketsandMarkets

DMCA.com Protection Status